PPARγ and colorectal carcinoma: Conflicts in a nuclear family (original) (raw)

Nature Medicine volume 4, pages 1004–1005 (1998) Cite this article

Abstract

Two new mouse studies suggest that PPARγ agonists may promote tumorigenesis in colon epithelium whereas a third study in humans indicates a possible protective role for these drugs (pages 1046–1061).

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

References

  1. Lehmann, J.M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270, 12953–12956 (1995).
    Article CAS Google Scholar
  2. Kliewer, S.A. et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83, 813–819 (1995).
    Article CAS Google Scholar
  3. Forman, B.M. et al. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83, 803–812 (1995).
    Article CAS Google Scholar
  4. Lehmann, J.M., Lenhard, J.M., Oliver, B.B., Ringold, G.M. & Kliewer, S.A. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272, 3406–3410 (1997).
    Article CAS Google Scholar
  5. Lefebvre, A.M. et al. Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APC_min_/+ mice. Nature Med. 4, 1053– 1057 (1998).
    Article CAS Google Scholar
  6. Saez, E. et al. Activators of the nuclear receptor PPARγ enhance polyp formation. Nature Med. 4, 1058–1061 (1998).
    Article CAS Google Scholar
  7. Sarraf, P. et al. Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nature Med. 4, 1046– 1052 (1998).
    Article CAS Google Scholar
  8. Dove, W.F. et al. The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions. Philos. Trans. R. Soc. Lond. B Biol. Sci. 353, 915–923 ( 1998).
    Article CAS Google Scholar
  9. Tontonoz, P. et al. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc. Natl. Acad. Sci. USA 94, 237–241 (1997).
    Article CAS Google Scholar
  10. Mueller, E. et al. Terminal differentiation of human breast cancer through PPARγ. Mol. Cell 1, 465–470 (1998).
    Article CAS Google Scholar
  11. Mansen, A., Guardiola-Diaz, H., Rafter, J., Branting, C. & Gustafsson, J.A. Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa. Biochem. Biophys. Res. Commun. 222, 844– 851 (1996).
    Article CAS Google Scholar
  12. Wasan, H.S., Novelli, M., Bee, J. & Bodmer, W.F. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. Proc. Natl. Acad. Sci. USA 94, 3308–3313 (1997).
    Article CAS Google Scholar

Download references

Acknowledgements

I thank R. Xavier and J. Avruch for helpful comments and B. Spiegelman for the communication of unpublished results.

Author information

Authors and Affiliations

  1. Department of Molecular Biology, Massachusetts General Hospital, Boston, 02114, Massachusetts, USA
    Brian Seed

Rights and permissions

About this article

Cite this article

Seed, B. PPARγ and colorectal carcinoma: Conflicts in a nuclear family.Nat Med 4, 1004–1005 (1998). https://doi.org/10.1038/1990

Download citation